PCRX

3 Hot Biotech Stocks Hitting Highs | Benzinga

The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks.
Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not.
Some biotech stocks, however, have performed better than others, and some have actually outperformed […]

PACIRA PHARMACEUTICALS, INC. Financials

moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

Pacira Pharmaceuticals, Inc. Announces sNDA Submission for EXPAREL Nerve Block Indication

[Business Wire] – Pacira Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for a nerve block indication for EXPAREL® . moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

Wider-than-Expected Loss at Pacira, Revs Up

moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[Business Wire] – Pacira Pharmaceuticals, Inc. today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference on Tuesday moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click […]

Pacira Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[Business Wire] – Pacira Pharmaceuticals, Inc. today announced the pricing of its previously announced public offering of 1,600,000 shares of its common stock at a public offering price of $64.00 per share. moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

4:01 pm Pacira Pharmaceuticals enters into strategic co-production partnership with Patheon to create additional EXPAREL manufacturing capacity; new manufacturing facility to meet future demand exceeding the est $400 mln of current producti

moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

4:31 pm Pacira Pharma announced additional Phase 3 data supporting the efficacy and safety of EXPAREL to achieve a femoral nerve block in patients undergoing total knee arthroplasty; sNDA submission expected in Q2 2014

moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]